BRIDGEPOINT takes majority stake in ALTANO

Bridgepoint has agreed to take a majority stake in the Altano Group, the world's largest network of equine clinics and practices, buying out existing investor Ufenau Capital Partners while founder Dr Victor Baltus, senior management and veterinary leaders stay invested. Media sources put the company at an enterprise value of , an EV/EBITDA of . Founded in 2017 and headquartered in Dülmen, Germany, Altano has brought together 110 equine clinics and ambulatory practices with almost 1,000 veterinarians across Europe, North America and Oceania, covering routine and emergency care, specialist referrals, advanced imaging, surgery, sports medicine and breeding. The deal adds to Bridgepoint's healthcare holdings, which include Identicare, Safe Life and Prescient Healthcare Group, and brings in Boris Zjacic as Group CEO, previously head of Artemis and COO of Diaverum, with Baltus becoming President. Carsten Kratz, Partner and Head of DACH at Bridgepoint, led the firm's interest. Bridgepoint was advised by J.P. Morgan and Rothschild & Co on M&A, Bain & Company on commercial, KPMG and EY on financial and tax, and Kirkland & Ellis on legal, while Jefferies advised the sell-side. The transaction is subject to customary closing conditions and is expected to complete by the end of 2026.